A Patient

Engagement

Partner

Gryt is owned and run by survivors and caregivers.

We keep patients and caregivers at the heart of everything we do.

Through a relentless focus on patient experience, we collaborate to enhance drug development, access to care, and outcomes for all.

Since 2018, Gryt has been a patient engagement partner to pharmaceutical and life science leaders.

  • Gryt has delivered 90 initiatives, all focused on engaging patients and providers to increase awareness, education, access and recruitment.

Logos of various pharmaceutical and healthcare companies, including Amgen, BluePrint Medicines, EMD Serono, Bayer, Bristol Myers Squibb, Gilead, Incyte, Pfizer, Syneos Health, Lilly, Seagen, and Takeda.

Gryt is a preferred supplier to global pharmaceutical, CRO and life sciences leaders

Our Services:

  • Community-Building

  • Direct to Patient Activities

  • Patient Insights Services/ RWE

  • Patient Engagement Technology

  • Study Websites

  • Patient Recruitment

  • Recruitment Materials

  • Patient/ Provider Campaigns

Our differentiator is that we co-create each initiative with patients living the diagnosis you’re working to recruit.

“Asking the patient,
’ok, so are you comfortable with that?’... to me is like reaching out and asking, what do you need so you feel like you fully understand what’s being communicated to you?”
— Barry Nelson, Lung Cancer Patient
A smiling man with a bald head, wearing a blue blazer and a blue checkered shirt, standing in front of a blurred bookshelf background.
  • A woman with long blonde hair smiling, wearing earrings and a gray cardigan, shows her face close-up against a dark background.

    “Gryt can find the answers to questions we can’t get from traditional EMR approaches”.

    Kimberly  Lowe, PhD, MHS
    Former Epidemiology Senior Manager, AMGEN

  • Woman with shoulder-length brown hair, glasses, and a dark top, standing outdoors near a tree, smiling

    “Gryt is an incredible platform to share and learn from our greatest stakeholders – our patients”.

    Cathy Florek
    Director, Head of Engagement Strategy, Bristol Myers Squibb